213 related articles for article (PubMed ID: 23916291)
1. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
[TBL] [Abstract][Full Text] [Related]
2. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
[TBL] [Abstract][Full Text] [Related]
3. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
6. p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.
Karim RZ; Gerega SK; Yang YH; Spillane A; Carmalt H; Scolyer RA; Lee CS
Histopathology; 2010 Jun; 56(7):868-75. PubMed ID: 20497245
[TBL] [Abstract][Full Text] [Related]
7. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
9. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
11. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
12. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.
Pirog EC; Quint KD; Yantiss RK
Am J Surg Pathol; 2010 Oct; 34(10):1449-55. PubMed ID: 20871219
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumors and fibroadenoma common beginning and different ending.
Oprić S; Oprić D; Gugić D; Granić M
Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
[TBL] [Abstract][Full Text] [Related]
14. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers distinguishing mammary fibroepithelial neoplasms: a tissue microarray study.
Lin CK; Tsai WC; Lin YC; Yu JC
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):433-41. PubMed ID: 25003838
[TBL] [Abstract][Full Text] [Related]
16. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
Chen PH; Bossuyt V; Reisenbichler E
Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
Djordjevic B; Hanna WM
Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
[TBL] [Abstract][Full Text] [Related]
18. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
19. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
